NxThera

NxThera

NxThera

NxThera pioneered its Convective Radiofrequency Water Vapor Thermal Therapy platform to treat a variety of endourological conditions beginning with BPH, which was FDA cleared in August 2015.
Type
B2c
Founded
2008
Raised
$12.2M
Follow us
Alexa global traffic share
Latest funding
$12,200,000
Venture capital - 2017
Team Size
50+
Employees
$12,200,000 Venture capital
MassDevice

NxThera raises $12.2m